For example, Federman et al. (2012) fabricated an anti-ALCAM-hybrid-polymerized liposomal NP which targets osteosarcoma-associated cell surface antigen ALCAM (Activated Leukocyte Cell Adhesion Molecule). Here, ALCAM is linked to osteosarcoma.